ADENOID CYSTIC CARCINOMA

Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADENOID CYSTIC CARCINOMA trials appear

Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1 Terminated 2

Experimental drug shows promise for rare cancer

Disease control Completed

This study tested the drug regorafenib in 38 people with a rare cancer called adenoid cystic carcinoma that had spread or come back. Regorafenib is already approved for other cancers and works by blocking tumor growth and blood vessel formation. The goal was to see if it could he…

Matched conditions: ADENOID CYSTIC CARCINOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 17, 2026 02:17 UTC

ADENOID CYSTIC CARCINOMA

Get alerted when new ADENOID CYSTIC CARCINOMA trials appear

Experimental drug shows promise for rare cancer